Also represented on

Selected projects

Fundraising

Closed Fundraising

Germany

2024

Status

Ongoing

The Speer Group supports the divestment process of an established private equity fund with a diversified portfolio in A to D locations. The assets are mostly mixed-use properties.

Speer Group successfully raised EUR 0.5 Mio. for a startup in the security & defence space.

project image
Divestiture

PERE Divestiture (EUR 1bn)

Deutschland

2024

Status

Ongoing

Die Speer Group unterstützt den Desinvestitions-prozess eines etablierten Private-Equity-Fonds mit einem diversifizierten Portfolio in A- bis D-Lagen. Die Assets sind überwiegend gemischt genutzte Immobilien.

Speer Group unterstützt derzeit den Desinvestitionsprozess eines Real Estate Portfolios im deutschen Markt. Sprechen Sie uns gerne darauf an.

project image
Market Entry

Market Entry DE (UAE)

Germany

2024

Status

Closed

Consultants at Speer Group have advised a UAE-based pharmaceutical company on the market entry strategy an corporate structure in Germany.

project image
Syndication

Capital Markets (Debt, Mezzanine)

Deutschland

2023 - 2024

Status

Closed

Berater der Speer Group unterstützten das Fundraising von Debt und Mezzanine Kapital in Höhe von 
EUR 3 bis 500 Millionen in deutschen Familienunternehmen.

Investing together

Get free access to selected co-investment opportunities today on a deal-by-deal basis (minimum investment: 200,000 EUR).

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
M&A

Rheinmetall — Automecanica

Germany

2023

Status

Closed

Speer Group consultants supported Rheinmetall's takeover of 72.5% of the Romanian company Automecanica Medias (now Rheinmetall Automecanica SRL).

M&A

Rheinmetall — REEQ B.V.

Germany

2023

Status

Closed

Speer Group consultants supported Rheinmetall's acquisition of Dutch automotive startup REEQ.

project image
Market Entry

Market Entry Italy and China

Germany

2022

Status

Closed

Consultants at Speer Group supported the advisory for the joint market entry of two pharmaceutical companies in Italy and China.

Schedule
COnsultation

calender img